A next generation drug for Overactive bladder, TRK-130, in a Phase-IIb clinical trial in Japan; Preclinical data of potent pharmacological effects based on modulation of neurotransmission.

Abstract Category

Neurourology: Basic Science

Links
	Abstract 177
	Urothelium and Signal Transmission Scientific Podium Poster Session 17
	Thursday 1st September 2011
	16:30 - 16:35
	Hall P4
	1. Toray Industries Inc. Pharmaceutical Research Laboratories, 2. Takeda Pharmaceutical Company Limited, 3. Ina research Inc., 4. Jikei University School of Medicine
Presenter
K Koji Kawai
Abstract PDF Edit Abstract Abstract Centre